pain. Analgesics, antipyretics and anti-inflammatory drugs
Conditions
Interventions
Intervention 1: Group I: Intra-articular injection of 40 mg/ml methylprednisolone and 1 ml sterile water in the operation room. Intervention 2: Group II: Intra-articular injection of 40 mg/ml methylpr
Placebo
Prevention
Group I: Intra-articular injection of 40 mg/ml methylprednisolone and 1 ml sterile water in the operation room.
Group II: Intra-articular injection of 40 mg/ml methylprednisolone
and 0.5 mg/kg ketamine in the operating room.
Sponsors
Vice chancellor for research, Ahwaz Jondishapour University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Pain due to arthritis; at least one month of unsuccessful treatment; positive radiological findings. Exclusion criteria: Pain due to inflammatory diseases; history of fractures of the knee; ankylosis of the knee; previous deformity such as genu varum; immunodeficiency; infection at the injection site; drug addiction; meniscal and ligament injuries of the knee; coagulation disorders.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: One and Three Months After Injection. Method of measurement: visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Akhondzadeh
Imam Khomeini Hospital
Outcome results
None listed